drugset / Trial / NCT02020161
Clinical Guidelines for APL Treatment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Therapeutic guidelines for treatment of patients with de novo APL to be used by every institution that wants to follow them. All patients who are reported may be retrospectively analyzed
Timeline
- Start
- 2012-06
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Idarubicin | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Tretinoin | Small molecule | — | — |